Alexander Stuart Douglas | Academic Influence

Alexander Stuart Douglas's AcademicInfluence.com Rankings

Alexander Stuart Douglas

Philosophy

#6097

World Rank

#9070

Historical Rank

Logic

#3379

World Rank

#4526

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Alexander Stuart Douglas's Degrees

Bachelors Biology Stanford University

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Alexander Stuart Douglas Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Alexander Stuart Douglas FRSE FRCP was a physician and haematologist. He was Regius Professor of Medicine at Aberdeen University from 1970 to 1985. He received international acclaim for his discoveries in relation to blood coagulation, causes of abnormal bleeding, and causes of thrombosis. He played a key role in identifying the role of anticoagulants and antiplatelet agents in preventing heart attacks, setting a modern benchmark for the treatment of heart disease.

(See a Problem?)

Alexander Stuart Douglas's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Thromboplastin Generation Test (1953) (624)
Christmas Disease (1952) (298)
Deep venous thrombosis of the legs after strokes. Part I--incidence and predisposing factors. (1976) (189)
Seasonal variation in coronary heart disease in Scotland. (1995) (149)
Fibrinolytic Enzyme System and Pregnancy (1969) (140)
Coagulation and Fibrinolytic Systems in Pre-eclampsia and Eclampsia (1971) (131)
A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction. (1973) (127)
The formation of thromboplastin in human blood (1953) (125)
Coagulation and Fibrinolytic Mechanisms During and After Normal Childbirth (1970) (122)
Venous thrombosis following strokes. (1972) (122)
Seasonality of disease in Kuwait (1991) (98)
Tranexamic Acid in Control of Haemorrhage after Dental Extraction in Haemophilia and Christmas Disease (1972) (98)
Familial thrombosis: inherited deficiency of antithrombin III. (1978) (95)
Fibrin Degradation Products in Normal and Abnormal Pregnancy and Parturition (1969) (88)
The Incidence and Significance of Iron-containing Granules in Human Erythrocytes and their Precursors (1953) (86)
The Measurement of Prothrombin in Plasma (1953) (82)
Disseminated intravascular coagulation: a review. (1978) (78)
The initial stages of blood coagulation (1953) (74)
Haemostatic Mechanism in the Uterine Circulation during Placental Separation (1970) (70)
Hereditary Heinz-body Anaemia, Thrombocyttopenia, and Haemoglobinopathy (Hb Köln) in a Glasgow Family (1964) (65)
The action of thromboplastic substances (1953) (62)
RAISED PLASMA ŒSTRADIOL AND ŒSTRONE LEVELS IN YOUNG SURVIVORS OF MYOCARDIAL INFARCTION (1978) (62)
Amino Methyl Cyclohexane Carboxylic Acid (AMCHA), A New Synthetic Fibrinolytic Inhibitor (1965) (62)
ε-AMINOCAPROIC ACID AND OTHER INHIBITORS OF FIBRINOLYSIS (1964) (52)
The Relationship between Platelet Aggregation and Time Interval after Venepuncture (1974) (51)
Treatment of Peripheral Arterial Occlusion by Streptokinase Perfusion (1963) (50)
In-vitro and In-vivo Studies of a Preparation of Urokinase (1963) (49)
Diagnosis of deep vein thrombosis using autologous indium-III-labelled platelets. (1981) (49)
The effect of age upon the coagulation system (1974) (49)
Renal complications in haemophilia and Christmas disease. (1971) (48)
Familial antithrombin III deficiency. (1982) (48)
Frequency of venous thrombosis in patients with an exacerbation of chronic obstructive lung disease. (1983) (44)
Deep venous thrombosis of the legs after strokes: Part 2-Natural history. (1976) (43)
The effect of age on the fibrinolytic enzyme system (1974) (39)
Changes in platelet behaviour during arvin therapy. (1969) (39)
Coagulation and fibrinolytic systems in pre-eclampsia and eclampsia. (1971) (38)
Plasminogen-activator-producing Tumour (1969) (38)
Studies on Blood Coagulation, Fibrinolysis and Platelet Function Following Exercise in Normal and Splenectomized People (1972) (38)
SOME PROPERTIES OF THE ANTIFIBRINOLYTICALLY ACTIVE ISOMER OF AMINO-METHYLCYCLOHEXANE CARBOXYLIC ACID. (1964) (37)
Fibrinogen Level as a Predictor of Mortality in Survivors of Myocardial Infarction (1991) (36)
Effects on blood coagulation, fibrinolysis, and platelet aggregation of normal and atheromatous aortic tissue (1966) (35)
The inhibition of urokinase by alpha 2 -macroglobulin. (1973) (35)
Mode of action of coumarin drugs. (1955) (34)
EFFECT OF ANTICOAGULANT DRUGS ON PLATELET AGGREGATION IN THE CHANDLER'S TUBE. (1965) (33)
In vitro and In vivo Studies with Trasylol, an Anticoagulant and a Fibrinolytic Inhibitor (1968) (33)
THE BLOOD COAGULATION AND FIBRINOLYTIC SYSTEMS IN THE NEWBORN AND THE MOTHER AT BIRTH (1971) (32)
Platelet abnormality in human scurvy. (1967) (31)
Neurological Complications of Haemophilia and Christmas Disease (1956) (26)
Gastrointestinal bleeding in haemophilia. (1973) (26)
The effeCt of vitamin c supplements on serum cholesterol, coagulation, fibrinolysis and platelet adhesiveness. (1975) (25)
Hypoprothrombinaemia in the Newborn (1955) (25)
Effect of RA233 on Platelet Function In Vitro (1970) (24)
The Effect on Dipyridamole on Platelet Aggregation and Adhesiveness (1968) (24)
Anticoagulants and Fibrinolysins (1963) (23)
Relationships between platelet function tests in normal and uraemic subjects (1970) (22)
Studies on atihemophilic factor (AHF, factor VIII) during labor in normal women, in patients with premature separation of the placenta, and in a patient with von Willebrand's disease (1974) (21)
The haemostatic defect following extracorporeal circulation (1966) (21)
Effect of gaboon viper (Bitis gabonica) venom on blood coagulation, platelets, and the fibrinolytic enzyme system (1969) (21)
Transfusion Studies in Patients with Familial Antithrombin III (ATIII) Deficiency: Half‐disappearance Time of Infused ATIII and Influence of such Infusion on Platelet Life‐span (1981) (20)
An Atypical Genetic Haemorrhagic Disease with Increased Concentration of a Natural Inhibitor of Prothrombin Consumption (1967) (20)
In‐Vitro Studies with Ancrod (‘Arvin’) (1971) (20)
Platelet adhesiveness, coagulation, and fibrinolytic activity in obesity (1972) (20)
Raised plasma oestradiol and oestrone levels in young survivors of myocardial infarction. (1978) (20)
Drug-induced neutropenia and agranulocytosis. (1962) (20)
Effect of fibrinogen degradation products on platelet aggregation (1968) (20)
Clinical Trial of Epsilon-aminocaproic Acid in Severe Haemophilia (1965) (19)
The action of heparin in the prevention of prothrombin conversion. (1956) (19)
Dental Extraction in Haemophilia and Christmas Disease (1957) (19)
Platelet Adhesiveness and Fibrinolysis after Recent Cerebro-Vascular Accidents and their Relationship with Subsequent Deep Venous Thrombosis of the Legs (1976) (18)
Plasma Fibrinolytic Activity in Renal Disease (1965) (18)
Further purification and properties of Hageman factor cofactor. (1972) (18)
THROMBOLYSIS STUDIED IN AN ARTIFICIAL CIRCULATION: THROMBI PREPARED IN VITRO IN A CHANDLER'S TUBE. (1965) (17)
Studies on an Inhibitor of Plasminogen Activators in Human Platelets (1974) (17)
Experience with streptokinase infusions. (1962) (17)
The effect of fat feeding on fibrinolysis, "Stypven" time and platelet aggregation. (1967) (17)
The fibrinolytic enzyme system after trauma and in patients with fat embolism. (1974) (16)
Indium-111 labelled platelets in diagnosis of leg-vein thrombosis: preliminary findings. (1980) (16)
Prophylactic antithrombotic therapy with stanozolol in patients with familial antithrombin III deficiency (1984) (16)
The Consumption of Some Components Involved in Physiological Blood Coagulation (1953) (16)
In vitro studies of staphylokinase. (1965) (16)
Aggregation of human platelets by commercial preparations of bovine and porcine antihaemophilic globulin (1972) (15)
Amyloidosis Associated with the Nephrotic Syndrome and Transfusion Reactions in a Haemophiliac (1971) (15)
Studies on the Anticoagulant Action of Aprotinin (“Trasylol”) (1970) (15)
Coagulant activity of the scorpion venoms Palamneus gravimanus and Leiurus quinquestriatus. (1974) (15)
Fits in Childhood (1965) (14)
EPSILON-AMINOCAPROIC ACID AND OTHER INHIBITORS OF FIBRINOLYSIS. (1964) (14)
Effect of Vitamin K on Hypoprothrombinaemia Induced by Dicoumarol and Tromexan (1952) (13)
Action of a Pyrimido-pyrimidine Compound on Platelet Behaviour in Vitro (1969) (13)
Effect of normal and atheromatous aortic tissue on platelet aggregation in vitro (1966) (13)
Pathological fibrinolytic states and their treatment with epsilon aminocaproic acid (EACA) (1966) (12)
Coronary Heart Disease in North-East Scotland: A Study of Genetic and Environmental Variation in Serum Lipoproteins and other Variables (1980) (12)
SOME OBSERVATIONS ON THE COAGULATION DEFECT IN VITAMIN K DEFICIENCY (1958) (12)
Inhibitors of Plasminogen Activation in Human Blood (1976) (12)
Studies on East African Snakes (1966) (11)
The Christmas factor deficiency in coumarin therapy. (1958) (11)
Cryoprecipitate Therapy in Haemophilia (1969) (11)
PREOPERATIVE FREQUENCY OF DEEP VENOUS THROMBOSIS IN PATIENTS WITH FRACTURED NECK OF FEMUR (1981) (10)
THE MEASUREMENT OF PROTHROMBIN IN PLASMA A CASE OF PROTHROMBIN DEFICIENCY (10)
Antihemophilic globulin assay following plasma infusions in hemophilia. (1958) (10)
THE BEHAVIOUR OF THE COAGULATION AND FIBRINOLYTIC MECHANISMS IN ABRUPTIO PLACENTAE (1969) (10)
Evidence linking familial thrombosis with a defective antithrombin III gene in two British kindreds. (1988) (10)
Lipoprotein Fractions and Antithrombin III Consumption During Clotting (1982) (10)
The contribution of plasma protease inhibitors to antiplasmin activity in man. (1976) (10)
A MEDICO–PSYCHIATRIC DIAGNOSTIC REVIEW OF REMANDED (WITHOUT A REQUEST FOR A PSYCHIATRIC REPORT) MALE MINOR OFFENDERS (1967) (10)
Estradiol levels in myocardial infarction. (1982) (9)
Circannual Rhythm of Arterial and Venous Thromboembolic Disease (1979) (8)
The fibrinolytic enzyme system in hypertension (1973) (8)
Anticoagulants and Anticoagulant Therapy: A Review (1952) (8)
TREATMENT OF PERIPHERAL VASCULAR OCCLUSION BY STREPTOKINASE PERFUSION. (1964) (8)
'PERSANTIN'-ASPIRIN REINFARCTION STUDY (1976) (8)
Oral anticoagulants in arterial disease. (1978) (8)
Aspirin and other antiplatelet drugs in the prophylaxis of thrombosis. (1987) (8)
DIAGNOSIS OF POST-TRANSPLANT RENAL HÆMATOMA WITH AUTOLOGOUS INDIUM-111 LABELLED PLATELETS (1980) (7)
Heparin: Metabolism, Physiology and Clinical Application (1964) (7)
The influence of personality on student reactions to clinical experience. (1972) (7)
Effect in vitro on platelet function of two compounds developed from the pyrimido-pyrimidines (1972) (7)
Studies with Complamin, a Nicotinic-acid/Theophylline Ester, as a Fibrinolytic Agent (1965) (7)
Antithrombotic treatment. (1983) (7)
Platelet electrophoresis: effect of defibrination by ancrod (Arvin). (1972) (7)
Arterial thrombosis and accelerated atheroma in a member of a family with familial antithrombin III deficiency (1982) (6)
Clinical Assessment of Haemoglobin Concentration (1957) (6)
MEGALOBLASTIC ANAEMIA IN ASSOCIATION WITH POLYCYTHAEMIA VERA. (1964) (6)
Antihemophilic globulin consumption during blood coagulation. (1956) (6)
Acquired Hypofibrinogenaemia—‘The Defibrination Syndrome’ (1967) (6)
Studies with a Preparation of Urokinase (1967) (6)
Anticoagulant and fibrinolytic drugs. (1968) (6)
Epsilon-Aminocaproic acid therapy in ulcerative colitis (1973) (5)
Diagnosis of aortic aneurysm using autologous platelets labelled with indium-111. (1981) (5)
Plasminogen activation and the coagulation process. (1969) (5)
Studies on the haemostatic mechanism following exercise. (1969) (4)
TOXICITY OF DRUGS. (1965) (4)
Familial venous thrombosis. (1983) (4)
Studies on the blood fibrinolytic system in congestive cardiac failure. (1973) (4)
Thrombolytic Therapy (1969) (4)
Fibrinolytic enzyme system (1969) (4)
Thrombosis after venography in familial antithrombin II deficiency. (1981) (4)
The effect of clofibrate on components of the fibrinolytic enzyme system. (1972) (4)
Effect of vitamin K preparations on hypoprothrombinaemia induced by dicoumarol and tromexan. (1952) (4)
Platelet function after the administration of chlorpromazine to human subjects. (1976) (3)
RABBIT (TO REPLACE HUMAN) BRAIN MATERIAL IN ANTICOAGULANT CONTROL (1986) (3)
Blood and neoplastic diseases. Haemostasis, haemorrhage, and thrombosis. (1974) (3)
Disorders of Thrombin Formation (1984) (3)
125I-LABELLED-FIBRINOGEN TEST: EFFECT OF 131I-ALBUMIN (1972) (3)
ŒSTROGENS, MYOCARDIAL INFARCTION, AND SMOKING (1978) (3)
Serum-triglyceride levels and stypven time. (1966) (3)
Paralysis of the legs and venous thromboembolism. (1973) (3)
Aortic thrombosis in antithrombin III deficiency. (1982) (3)
Hæmorrhagic Diseases in Surgery (1965) (2)
The effect of chlorpromazine and antihistamines on human blood platelets in vitro and in vivo. (1973) (2)
The influence of sodium salts of fatty acids on the fibrinolytic enzyme system (1973) (2)
Proceedings: The relationship between the time interval after venepuncture and the rate of platelet aggregation. (1974) (2)
In vitro and in vivo studies of trasylol. (1966) (2)
The coagulation defect caused by tromexan therapy. (1955) (2)
Litigation over illness associated with tryptophan is possible. (1992) (2)
Haemorrhagic and Thrombotic Diseases INGA MARIE NILSSON (1975) (2)
Abstracts of Papers Presented at a Meeting of the British Society for Haematology held in London, 11th January 1974 (1974) (2)
Some Effects of Trypsin and Streptokinase on Platelet Aggregation (1967) (2)
Cerebral changes related to anoxia, with report of a case. (1949) (2)
Problems related to fibrinolysis Physiology of fibrinolysis Clinical physiology of the fibrinolytic enzyme system (1)
The effect of streptokinase and trypsin on platelet aggregation in vitro. (1966) (1)
Deep Venous Thrombosis of the Legs after Strokes: Incidence, Natural History and Predisposing Factors (1975) (1)
Mechanisms of thrombotic disease. (1976) (1)
Individualisation of Oral Anticoagulant Therapy (1979) (1)
131 I-labelled-fibrinogen test: effect of 131 I-albumin. (1972) (1)
Thrombolytic therapy (1964) (1)
Thrombosis and Urokinase: Proceedings of the Serono Symposia, vol 9 (1978) (1)
Toxicity of Drugs (1965) (1)
The fibrinolytic enzyme system in haematological malignancy. (1973) (1)
Management of thrombotic diseases. (1971) (1)
ACUTE FIBRINOLYTIC STATES IN SURGERY. (1965) (1)
History of venous thrombo-embolic disease 1750--1900. (1978) (1)
Oral anticoagulants. (1981) (1)
Clinical physiology of the fibrinolytic enzyme system. (1972) (1)
Familial Thrombosis Due to Antithrombin III Deficiency: An Extensive Family Study (1977) (1)
Stanozolol Treatment in Patients with Familial ATIII Deficiency (1982) (1)
Relationships between platelet function tests in normal anduraemic subjects Assessment of Platelet Aggregation and Disaggregation (0)
Effect invitro on platelet function oftwocompounds developed fromthepyrimido-pyrimid ines (1972) (0)
Aplastic Anaemia (1979) (0)
ELECTRICAL STIMULATION OF THE BLADDER. (1965) (0)
Brown fields need special treatment (2006) (0)
VII.—Plasma Coagulation Factors (1972) (0)
TOXICITY OF ANTICOAGULANT DRUGS. (1965) (0)
Observations on the fedding of fatty acids from cerebrosides to patients with disseminated sclerosis. (1957) (0)
Blood Coagulation (1964) (0)
Book Review: Heparin: Metabolism, Physiology and Clinical Application (1964) (0)
Contents, Vol. 9, 1970 (1970) (0)
Thrombolytic Therapy (1964) (0)
The Relationship Of Lipids To Antithrombin Consumption During Clotting (1981) (0)
Arterial thrombosis andaccelerated atheroma inamemberofafamily withfamilial antithrombin IIIdeficiency (1982) (0)
Prevention and Treatment of Thrombosis (1969) (0)
Fibrinolysis and Urokinase. (1982) (0)
Di-isopropyl fluorophosphonate as an intestinal carminative. (1949) (0)
The Contribution of Individual Protease Inhibitors to Plasma Antiplasmin Activity (1975) (0)
ANTICOAGULANTS AFTER MYOCARDIAL INFARCTION (1981) (0)
Preoperative antithrombin III activities and lipoprotein concentrations as predictors of venous thrombosis in patients with fracture of neck of femur. (1983) (0)
PORTAL VENOGRAPHY. (1965) (0)
223. Aminocaproic acid and other inhibitors of fibrinolysis. (1966) (0)
THROMBOLYTIC THERAPY. (1964) (0)
ABORTION LAW. (1965) (0)
Book Review: Thrombosis and Urokinase. (1978) (0)
UROKINASE AND NON-ENZYMATIC FIBRINOLYTIC AGENTS. (1964) (0)
Letters to the EditorANTICOAGULANT THERAPY (1960) (0)
The anticoagulant action of puff adder (B. arietans) venom. (1965) (0)
Treatment of Hypoprothrombinaemic Haemorrhage (1952) (0)
A present concept of blood coagulation. (1960) (0)
Modern Concepts of Blood Coagulation and Its Disorders (1955) (0)
COAGULATION DEFECTS (1957) (0)
Book Review: Fibrinolysis and Urokinase (1982) (0)
Management of blood clotting defects in children. (1960) (0)
Studies with Complamin (1965) (0)
Contents, Vol. 8, 1969 (1966) (0)
[THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY]. (1964) (0)
General principles of anticoagulant therapy; criteria of effectiveness. (1966) (0)

This paper list is powered by the following services:

Other Resources About Alexander Stuart Douglas

en.wikipedia.org

What Schools Are Affiliated With Alexander Stuart Douglas?

Alexander Stuart Douglas is affiliated with the following schools: